A detailed history of Black Rock Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,658,095 shares of AGIO stock, worth $169 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,658,095
Previous 4,962,237 6.13%
Holding current value
$169 Million
Previous $111 Million 23.25%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$21.32 - $34.81 $6.48 Million - $10.6 Million
-304,142 Reduced 6.13%
4,658,095 $136 Million
Q4 2023

Feb 13, 2024

BUY
$19.97 - $24.53 $6.22 Million - $7.63 Million
311,226 Added 6.69%
4,962,237 $111 Million
Q3 2023

Nov 13, 2023

SELL
$24.36 - $28.18 $1.83 Million - $2.12 Million
-75,263 Reduced 1.59%
4,651,011 $115 Million
Q2 2023

Aug 11, 2023

SELL
$21.38 - $29.19 $1.94 Million - $2.65 Million
-90,801 Reduced 1.88%
4,726,274 $134 Million
Q1 2023

May 12, 2023

BUY
$21.74 - $30.93 $1.05 Million - $1.49 Million
48,201 Added 1.01%
4,817,075 $111 Million
Q4 2022

Feb 13, 2023

SELL
$24.81 - $31.52 $562,393 - $714,495
-22,668 Reduced 0.47%
4,768,874 $134 Million
Q3 2022

Nov 14, 2022

SELL
$19.51 - $34.14 $906,649 - $1.59 Million
-46,471 Reduced 0.96%
4,791,542 $136 Million
Q2 2022

Aug 12, 2022

SELL
$17.06 - $31.42 $6.21 Million - $11.4 Million
-363,927 Reduced 7.0%
4,838,013 $107 Million
Q1 2022

May 12, 2022

SELL
$26.68 - $34.81 $5.51 Million - $7.19 Million
-206,596 Reduced 3.82%
5,201,940 $151 Million
Q4 2021

Feb 10, 2022

SELL
$29.58 - $49.78 $10.3 Million - $17.4 Million
-348,591 Reduced 6.05%
5,408,536 $178 Million
Q3 2021

Nov 09, 2021

SELL
$41.92 - $58.18 $9.11 Million - $12.6 Million
-217,380 Reduced 3.64%
5,757,127 $266 Million
Q2 2021

Aug 11, 2021

BUY
$52.06 - $61.27 $311 Million - $366 Million
5,974,507 New
5,974,507 $329 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.99B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.